JP5265144B2 - Novel process for producing 3-O-substituted-catechin derivatives - Google Patents

Novel process for producing 3-O-substituted-catechin derivatives Download PDF

Info

Publication number
JP5265144B2
JP5265144B2 JP2007168786A JP2007168786A JP5265144B2 JP 5265144 B2 JP5265144 B2 JP 5265144B2 JP 2007168786 A JP2007168786 A JP 2007168786A JP 2007168786 A JP2007168786 A JP 2007168786A JP 5265144 B2 JP5265144 B2 JP 5265144B2
Authority
JP
Japan
Prior art keywords
formula
group
compound
following formula
hydroxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007168786A
Other languages
Japanese (ja)
Other versions
JP2009007272A (en
Inventor
政範 竹川
素代 村田
範行 中島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Prefecture
Toa Pharmaceuticals Co Ltd
Original Assignee
Toyama Prefecture
Toa Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Prefecture, Toa Pharmaceuticals Co Ltd filed Critical Toyama Prefecture
Priority to JP2007168786A priority Critical patent/JP5265144B2/en
Publication of JP2009007272A publication Critical patent/JP2009007272A/en
Application granted granted Critical
Publication of JP5265144B2 publication Critical patent/JP5265144B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Pyrane Compounds (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a new method for producing a 3-O-substituted-catechin derivative having various acyl groups and alkyl groups substituted to the 3-hydroxy group of the flavan skeleton of catechins. <P>SOLUTION: The method for easily producing a 3-O-substituted-catechin derivative expressed by formula (IV) in high purity and yield comprises the selective introduction of various acyl groups and alkyl groups to the 3-hydroxy group of the flavan skeleton of catechins by selectively protecting only the phenolic hydroxy groups of catechins. <P>COPYRIGHT: (C)2009,JPO&amp;INPIT

Description

本発明は、カテキン類のフラバン骨格における3位の水酸基に様々なアシル基、アルキル基が置換した3−O−置換−カテキン類誘導体の新規な製造方法に関する。   The present invention relates to a novel method for producing 3-O-substituted-catechin derivatives having various acyl groups and alkyl groups substituted on the hydroxyl group at the 3-position in the flavan skeleton of catechins.

ポリフェノール化合物の一種であるフラバン−3−オール類の代表的な化合物であるカテキン類は、(−)−エピカテキン、(−)−エピガロカテキン、又はこれらの没食子酸エステルである(−)−エピカテキン ガレート、(−)−エピガロカテキン ガレートの4種類が主なものである。
カテキン類には、抗酸化作用、抗菌作用、消臭作用、血中コレステロール抑制作用、α−アミラーゼ活性阻害作用等の様々な化学的・生理的活性作用が知られている。また、最近、3−アシルカテキン類に子宮頸ガンの抑制作用(特許文献1)、DNA合成阻害作用(特許文献2)があることが開示された。しかし、これらカテキン類は難溶性物質であるため、注射剤として開発することが困難であり、吸収効率の向上を目的にDPI製剤化を検討する場合、大量の化合物が必要となるため大量合成が可能な3−O−置換−カテキン類誘導体の新規な合成法の開発が望まれていた。
The catechins that are representative compounds of the flavan-3-ols that are one type of polyphenol compounds are (−)-epicatechin, (−)-epigallocatechin, or gallic acid esters thereof (−) —. There are four main types: epicatechin gallate and (−)-epigallocatechin gallate.
Catechins are known to have various chemical and physiological activity actions such as an antioxidant action, an antibacterial action, a deodorizing action, a blood cholesterol suppressing action, and an α-amylase activity inhibiting action. Recently, it has been disclosed that 3-acylcatechins have an action of suppressing cervical cancer (Patent Document 1) and an effect of inhibiting DNA synthesis (Patent Document 2). However, since these catechins are poorly soluble substances, it is difficult to develop them as injections, and when considering DPI formulation for the purpose of improving absorption efficiency, a large amount of compounds are required, so that large-scale synthesis is possible. Development of a novel synthesis method of possible 3-O-substituted-catechin derivatives has been desired.

カテキン類は、主にツバキ科に属する茶樹の葉、茎、木部、樹皮、根、実、種子のいずれかから水、熱水、有機溶媒、含水有機溶媒あるいはこれらの混合溶媒等により抽出することにより得られる。カテキン類の精製物に関しては、例えば、茶葉を上記の溶媒で抽出して得られた抽出物を、有機溶媒分画や吸着樹脂等を用いて、所望の程度に精製することができる(特許文献3)。   Catechin is extracted from any of the leaves, stems, xylem, bark, roots, berries, seeds of tea trees belonging to the camellia family with water, hot water, organic solvents, hydrous organic solvents, or mixed solvents thereof. Can be obtained. With regard to purified products of catechins, for example, an extract obtained by extracting tea leaves with the above solvent can be purified to a desired degree using an organic solvent fraction or an adsorption resin (Patent Literature). 3).

一方、カテキン類のフラバン骨格における3位の水酸基に置換基を導入する方法としては、遊離型カテキンの存在下エステル化合物にカルボキシエステラーゼを作用させ、3−アシル化カテキンとする製造方法(特許文献4)、公知の3’,4’,5,7−テトラ−O−ベンジル−フラバン−3−オール(非特許文献1)の3位の水酸基にアシル基を導入し、得られた3−アシル化3’,4’,5,7−テトラ−O−ベンジル−フラバンの保護基であるベンジル基を脱保護して、3−アシル化3’,4’,5,7−テトラヒドロキシフラバン−3−オールを製造する方法(例えば、特許文献1)、ホウ素化合物を用いたカテキン誘導体の合成法(特許文献5、6)、トリフルオロ酢酸と酸塩化物を用いる方法(非特許文献2)、リパーゼを用いる方法(非特許文献3)等が開示されている。   On the other hand, as a method for introducing a substituent into the hydroxyl group at the 3-position in the flavan skeleton of catechins, a production method in which carboxyesterase is allowed to act on an ester compound in the presence of free catechin (Patent Document 4) ), An acyl group introduced into the hydroxyl group at the 3-position of known 3 ′, 4 ′, 5,7-tetra-O-benzyl-flavan-3-ol (Non-patent Document 1), and the resulting 3-acylation The benzyl group which is the protecting group of 3 ′, 4 ′, 5,7-tetra-O-benzyl-flavan is deprotected to give 3-acylated 3 ′, 4 ′, 5,7-tetrahydroxyflavan-3- A method for producing oale (for example, Patent Document 1), a method for synthesizing a catechin derivative using a boron compound (Patent Documents 5 and 6), a method using trifluoroacetic acid and an acid chloride (Non-Patent Document 2), a lipase for The method (Non-patent Document 3) have been disclosed that.

しかしながら、従来の合成法は、例えば、3’,4’,5,7−テトラ−O−ベンジル−フラバン−3−オールを用いる場合、ベンジル基の保護基を水素雰囲気化、パラジウム等の触媒を加えベンジル基を脱保護するため、安全性の研鑽を要することに加え、副反応物の生成による分離精製等の操作性や、再現性の問題から大量合成しにくい等の問題があった。また、前記特許文献4の製法は、酵素としてエステラーゼを用いるため操作が煩雑であった。   However, in the conventional synthesis method, for example, when 3 ′, 4 ′, 5,7-tetra-O-benzyl-flavan-3-ol is used, the protecting group of benzyl group is changed to a hydrogen atmosphere, and a catalyst such as palladium is used. In addition to deprotection of the benzyl group, in addition to requiring safety studies, there were problems such as operability such as separation and purification by the generation of by-products and difficulty in mass synthesis due to reproducibility problems. Further, the production method of Patent Document 4 uses an esterase as an enzyme, and thus the operation is complicated.

また、フェノール性水酸基を保護することなくアシルクロライドと反応させ、3位に選択的にアシル基を導入する方法が開示されているが、反応副生成物が多く、分離精製が非常に煩雑であり、大量合成するには実用的とはいえず、より簡便な、大量合成できる改良された製造方法の出現が望まれていた。   In addition, a method is disclosed in which an acyl group is selectively introduced at the 3-position by reacting with an acyl chloride without protecting the phenolic hydroxyl group, but there are many reaction by-products and separation and purification is very complicated. However, it has not been practical for mass synthesis, and there has been a demand for the appearance of an improved production method capable of mass synthesis that is simpler.

本発明者らは、カテキン類のフェノール性水酸基とアルコール性水酸基が保護されていない出発原料のカテキン類に、極性溶媒中、シリル化剤を反応させることによりフェノール性水酸基のみが選択的に高収率でシリル化されることを見出した。
このシリル化物、例えば、3’,4’,5,7−テトラ−t−ブチルジメチルシリル−(+)−カテキンは、文献公知の化合物である(特許文献7)が、その製造方法は、最初に(−)エピカテキン ガレートの水酸基を全てシリル基で保護し、次いで、テトラヒドロフラン溶媒中、水素化リチウムアルミニウムを反応させ、3位のみのシリル基を脱離して得る方法であり、フェノール性水酸基のみに、選択的に直接シリル保護基を導入することについては記載がない。
The inventors of the present invention selectively recover only the phenolic hydroxyl group by reacting the starting material catechins in which the phenolic hydroxyl group and alcoholic hydroxyl group of the catechins are not protected with a silylating agent in a polar solvent. It was found to be silylated at a rate.
This silylated product, for example, 3 ′, 4 ′, 5,7-tetra-t-butyldimethylsilyl-(+)-catechin is a compound known in the literature (Patent Document 7). (-) Epicatechin is a method in which all hydroxyl groups of gallate are protected with silyl groups, and then reacted with lithium aluminum hydride in a tetrahydrofuran solvent to remove the silyl group only at the 3-position. However, there is no description about directly introducing a silyl protecting group selectively.

特開2006−249056号公報JP 2006-249056 A 特開2006−249057号公報JP 2006-249057 A 特公平1−44232号公報Japanese Examined Patent Publication No. 1-44422 特開平6−279430号公報JP-A-6-279430 特開昭57−118580号公報JP 57-118580 A 特開昭57−120584号公報Japanese Patent Laid-Open No. 57-12058 米国特許公開公報2007−21384号公報US Patent Publication No. 2007-21384 木材学会誌、1991,37,488−493頁Journal of the Wood Society of Japan, 1991, 37, 488-493 Bioorganic & Medicinal Chemistry Letters,2000,10,1673−1675頁Bioorganic & Medicinal Chemistry Letters, 2000, 10, 1673-1675. Journal of Molecular Catalysis B:Enzymatic,2000,10,577−582頁Journal of Molecular Catalysis B: Enzymatic, 2000, 10, 577-582.

したがって本発明は、カテキン類のフラバン骨格における3位の水酸基に様々なアシル基又はアルキル基が置換した、3−O−置換−カテキン類誘導体の新規な製造方法を提供することを課題とする。   Therefore, an object of the present invention is to provide a novel method for producing a 3-O-substituted-catechin derivative in which various acyl groups or alkyl groups are substituted on the hydroxyl group at the 3-position in the flavan skeleton of catechins.

本発明者らは、上記課題を解決するために鋭意検討した結果、市販の出発原料であるカテキン類のフェノール性水酸基のみを、シリル基で選択的に保護することに成功し、保護されていない3位の水酸基にアシル基又はアルキル基を選択的に導入した後、次いでシリル基を脱保護することにより、目的とする3−O−置換−カテキン類誘導体が高収率で得られることを見出し本発明に至った。   As a result of intensive studies to solve the above problems, the present inventors have succeeded in selectively protecting only the phenolic hydroxyl group of catechins, which are commercially available starting materials, with a silyl group and are not protected. After selectively introducing an acyl group or an alkyl group into the hydroxyl group at the 3-position, and then deprotecting the silyl group, it was found that the desired 3-O-substituted-catechin derivatives can be obtained in high yield. The present invention has been reached.

したがって本発明は、次式(I):   Accordingly, the present invention provides the following formula (I):

Figure 0005265144
Figure 0005265144

(式中、Raは水素原子又は水酸基を表す。)
で示されるカテキン類に、塩基の存在下、次式:
A−X
(式中、Aは水酸基のシリル保護基をあらわし、Xは活性残基を表す。)
で示される化合物と反応させ、式(I)のフェノール性水酸基に選択的に保護基を導入した次式(II):
(In the formula, Ra represents a hydrogen atom or a hydroxyl group.)
In the presence of a base, the following formula:
AX
(In the formula, A represents a silyl protecting group for a hydroxyl group, and X represents an active residue.)
Wherein the protecting group is selectively introduced into the phenolic hydroxyl group of formula (I):

Figure 0005265144
Figure 0005265144

(式中、Rcは水素原子又は基:OAを表し、Aは前記定義と同一である)
で表される化合物とし、次いで下記式(V):
R−Y (V)
[式中、Rは炭素数1〜22の置換されていてもよいアルキル基、又はRbC(=O)−基で表されるアシル基(Rbは炭素数1〜22の置換されていてもよいアルキル基を表す)を表し、Yは活性残基を表す]
で表される化合物と反応させ、下記式(III):
(Wherein Rc represents a hydrogen atom or a group: OA, and A is the same as defined above)
And then the following formula (V):
RY (V)
[Wherein, R represents an alkyl group having 1 to 22 carbon atoms which may be substituted, or an acyl group represented by an RbC (═O) — group (Rb may be substituted having 1 to 22 carbon atoms. Represents an alkyl group, and Y represents an active residue]
And a compound represented by the following formula (III):

Figure 0005265144
Figure 0005265144

(式中、A、Ra及びRは前記定義と同一である)
で表される化合物とした後、脱保護をすることを特徴とする下記式(IV):
(Wherein A, Ra and R are the same as defined above)
And then deprotecting the compound represented by the following formula (IV):

Figure 0005265144
Figure 0005265144

(式中、Ra及びRは前記定義と同一である)
で表される3−O−アシル又はアルキル置換−カテキン類誘導体の製造方法である。
(Wherein Ra and R are as defined above)
A method for producing a 3-O-acyl or alkyl-substituted catechin derivative represented by the formula:

より具体的には、本発明は、式中Aがシリル保護基であり、特にシリル保護基が、t−ブチルジメチルシリル基である上記の製造方法である。   More specifically, the present invention is the above production method, wherein A is a silyl protecting group, and particularly the silyl protecting group is a t-butyldimethylsilyl group.

また本発明は、具体的には、上記の式(III)の化合物から式(IV)の化合物への脱保護を、溶媒中、酢酸の存在下、テトラブチルアンモニウムフルオリドを用いて行うことを特徴とする製造方法である。   In addition, the present invention specifically includes the deprotection of the compound of formula (III) to the compound of formula (IV) using tetrabutylammonium fluoride in a solvent in the presence of acetic acid. This is a featured manufacturing method.

さらにまた本発明は、上記の式(II)の化合物を単離することなく式(III)への誘導をワンポットで反応させる製造方法である。   Furthermore, the present invention is a production method in which the induction to the formula (III) is reacted in one pot without isolating the compound of the above formula (II).

また本発明は上記の製造方法における中間化合物の製造方法であり、具体的には、上記の式(I)の化合物におけるフェノール性水酸基に選択的に保護基を導入した式(II)で示される化合物の製造方法であり、また、式(IV)で示される化合物の製造方法である。   The present invention is also a method for producing an intermediate compound in the above production method, specifically, represented by the formula (II) in which a protecting group is selectively introduced into the phenolic hydroxyl group in the compound of the above formula (I). It is a manufacturing method of a compound, and is also a manufacturing method of the compound shown by Formula (IV).

本発明が提供する製造方法により、カテキン類のフラバン骨格における3位の水酸基に、選択的に様々なアシル基又はアルキル基を導入することができ、その結果、種々の3−O−アシル置換又は3−O−アルキル置換−カテキン類誘導体を簡便で、純度良く、かつ収率の良く製造できる方法を提供することができる。   According to the production method provided by the present invention, various acyl groups or alkyl groups can be selectively introduced into the hydroxyl group at the 3-position in the flavan skeleton of catechins, and as a result, various 3-O-acyl substitutions or It is possible to provide a method by which 3-O-alkyl-substituted-catechin derivatives can be easily produced with high purity and high yield.

本発明が提供する製造方法は、具体的には、次式に示す反応式で表すことができる。   Specifically, the production method provided by the present invention can be represented by the reaction formula shown below.

Figure 0005265144
Figure 0005265144

[上記反応式中、Raは水素原子又は水酸基を表し、Rcは水素原子又は基:−OAを表し、Aは水酸基のシリル保護基を表し、Xは活性残基を表し、Rは炭素数1〜22の置換されていてもよいアルキル基、又はRbC(=O)−基で表されるアシル基(Rbは炭素数1〜22の置換されていてもよいアルキル基を表す)を表し、Yは活性残基を表す] [In the above reaction formula, Ra represents a hydrogen atom or a hydroxyl group, Rc represents a hydrogen atom or group: —OA, A represents a silyl protecting group for a hydroxyl group, X represents an active residue, and R represents a carbon number of 1 Represents an optionally substituted alkyl group having ˜22 or an acyl group represented by an RbC (═O) — group (Rb represents an optionally substituted alkyl group having 1 to 22 carbon atoms), Y Represents an active residue]

以下、本発明における用語及び各工程について説明する。
本発明が提供する製造方法において、出発原料として用いるカテキン類(I)としては、カテキン、エピカテキン、ガロカテキン、エピガロカテキン等が挙げられ、天然又は合成品として文献公知の方法により、例えばカテキンは茶樹より得ることができる。
また、茶以外の植物からも、茶の場合と同様の方法により製造することができる。
これらのカテキン類は市販されており、例えば三井農林(株)製「ポリフェノン」、太陽化学(株)製「サンフェノン」、(株)伊藤園製「テアフラン」等を挙げることができる。
Hereinafter, terms and steps in the present invention will be described.
In the production method provided by the present invention, catechins (I) used as starting materials include catechin, epicatechin, gallocatechin, epigallocatechin and the like. Natural or synthetic products such as catechin can be obtained by methods known in the literature. It can be obtained from tea plant.
Moreover, it can manufacture from plants other than tea by the same method as in the case of tea.
These catechins are commercially available, and examples thereof include “Polyphenone” manufactured by Mitsui Norin Co., Ltd., “Sunphenon” manufactured by Taiyo Kagaku Co., Ltd., “Theafuran” manufactured by ITO EN Co., Ltd. and the like.

本発明において、置換基「Ra」は水素原子、又は水酸基を表す。したがって、式(I)で示されるカテキン類における2−位のフェニル基は、具体的には、例えば、3,4−ジヒドロキシフェニル、3,4,5−トリヒドロキシフェニル等を挙げることができる。   In the present invention, the substituent “Ra” represents a hydrogen atom or a hydroxyl group. Therefore, specific examples of the 2-position phenyl group in the catechins represented by the formula (I) include 3,4-dihydroxyphenyl, 3,4,5-trihydroxyphenyl, and the like.

置換基「A」で示される水酸基のシリル保護基としては、メチルシリル、エチルシリル、ジメチルシリル、ジエチルシリル、トリメチルシリル、トリエチルシリル、トリイソプロピルシリル、トリt−ブチルシリル、ジメチルt−ブチルシリル、トリメトキシシリル、トリエトキシシリル、ジフェニルメチルシリル、ジフェニルエチルシリル、ジフェニルイソプロピルシリル、ジフェニルt−ブチルシリル、トリフェニルシリル、トリフェノキシシリル、ジメチルメトキシシリル、ジメチルフェノキシシリル、メチルメトキシフェニルシリル基等のシリル保護基を挙げることができる。そのなかでも、t−ブチルジメチルシリル基が最も好ましい。
「X」は活性残基を示し、具体的にはハロゲン原子、トリフラート、N−メチルトリフルオロアセトアミド、イミダゾール等の、常法として用いられる活性残基を挙げることができる。そのなかでも、ハロゲン原子が好ましい。
The silyl protecting group of the hydroxyl group represented by the substituent "A", main Chirushiriru, ethylsilyl, dimethylsilyl, diethylsilyl, trimethylsilyl, triethylsilyl, triisopropylsilyl, tri t- butylsilyl, dimethyl t- butylsilyl, trimethoxysilyl, List silyl protecting groups such as triethoxysilyl, diphenylmethylsilyl, diphenylethylsilyl, diphenylisopropylsilyl, diphenyl t-butylsilyl, triphenylsilyl, triphenoxysilyl, dimethylmethoxysilyl, dimethylphenoxysilyl, methylmethoxyphenylsilyl groups Can do. Among these, t-butyldimethylsilyl group is most preferable.
“X” represents an active residue, and specific examples include an active residue used in a conventional manner such as a halogen atom, triflate, N-methyltrifluoroacetamide, imidazole and the like. Among these, a halogen atom is preferable.

ハロゲン原子としては、フッ素、塩素、臭素、ヨウ素のハロゲンであり、塩素、臭素、ヨウ素が好ましい。
したがって、式A−Xで表される化合物としては、例えば、市販のt−ブチルジメチルシリルクロライド(式:TBDM−Xで表される)を好ましく使用することができる。
The halogen atom is a halogen such as fluorine, chlorine, bromine or iodine, preferably chlorine, bromine or iodine.
Therefore, as a compound represented by Formula AX, for example, commercially available t-butyldimethylsilyl chloride (represented by Formula: TBDM-X) can be preferably used.

本発明の製法によれば、例えば、適当な溶媒、好ましくは特定の混合溶媒中、塩基の存在下、カテキン類とt−ブチルジメチルシリルクロライド(TBDM−X)とを反応させることにより、フェノール性水酸基に選択的にシリル保護基を導入することができる。
なお、式(I)のカテキン類において置換基Raが水酸基の場合には、当該水酸基はフェノール水酸基であることから、上記の反応により、シリル保護基で保護されることとなる[式(II)の化合物において、置換基Rcが基:−OAである化合物]。
According to the production method of the present invention, for example, by reacting catechins with t-butyldimethylsilyl chloride (TBDM-X) in the presence of a base in a suitable solvent, preferably a specific mixed solvent, phenolic A silyl protecting group can be selectively introduced into the hydroxyl group.
In the catechins of the formula (I), when the substituent Ra is a hydroxyl group, the hydroxyl group is a phenol hydroxyl group, and thus is protected by a silyl protecting group by the above reaction [formula (II) In which the substituent Rc is a group: -OA].

また本発明の製造方法において、式(II)の化合物と反応する次式(V):
R−Y (V)
で示される化合物において、例えば、式:
Rb(=CO)−Y
で表されるアシル活性体としては、Rbが炭素数2〜22であるものであり、例えばブタノイル、ペンタノイル、ヘキサノイル、ヘプタノイル、オクタノイル、デカノイル、ラウロイル、ミリストイル、パルミトイル、ステアロイル、ベヘノイル等のアシル基又はRbが鎖上に複数の不飽和結合を有していてもよい炭素数が2〜22の不飽和脂肪酸基、例えばオレイル、ゲラニル又は飽和脂肪酸基が炭素数1〜4のアルキルで置換されていてもよいイソステアロイル等のアシル基である活性体を挙げることができる。
In the production method of the present invention, the following formula (V) reacting with the compound of the formula (II):
RY (V)
For example, in the compound represented by the formula:
Rb (= CO) -Y
As the acyl activated compound represented by the formula, Rb is one having 2 to 22 carbon atoms. Rb may have a plurality of unsaturated bonds on the chain. The unsaturated fatty acid group having 2 to 22 carbon atoms, for example, oleyl, geranyl or saturated fatty acid group is substituted with alkyl having 1 to 4 carbon atoms. The active form which is acyl groups, such as a good isostearoyl, can be mentioned.

また、式:R−YにおけるRとしての炭素数1〜22のアルキル基としては、例えばブチル基、ペンチル基、ヘキシル基、ヘプチル基、オクチル基、デカン基、ラウリル基、ミリスチル基、パルミチル基、ステアリル基、ベヘニル基等の無置換のアルキル基、又は鎖上に複数の不飽和結合有する炭素数が2〜22の不飽和アルキル基、例えばオレイル基、ゲラニル基、又は炭素数1〜4のアルキル基で置換されているアルキル基を挙げることができる。   Moreover, as a C1-C22 alkyl group as R in Formula: RY, for example, a butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, a decane group, a lauryl group, a myristyl group, a palmityl group, An unsubstituted alkyl group such as a stearyl group or a behenyl group, or an unsaturated alkyl group having 2 to 22 carbon atoms having a plurality of unsaturated bonds on the chain, such as an oleyl group, a geranyl group, or an alkyl group having 1 to 4 carbon atoms Mention may be made of alkyl groups substituted with groups.

基「Y」活性残基であり、前記「X」と同一の活性残基等、常法用いられるものを挙げることができる。好ましくは前記したハロゲン原子を挙げることができ、ハロゲン原子としては、塩素、臭素、ヨウ素が好ましく、又は通常用いられるカルボン酸誘導体の活性残基を挙げることができる。   The group “Y” is an active residue, and the same active residue as the above “X” can be used. Preferably, the above-mentioned halogen atom can be mentioned, and as the halogen atom, chlorine, bromine and iodine are preferable, or an active residue of a commonly used carboxylic acid derivative can be mentioned.

本発明の製造方法における式(III)の化合物より式(IV)の化合物へ誘導する水酸基の保護基の脱保護は、公知の方法(T. W. Green, "Protective Groups in Organic Synthesis", A Wiley-Interscience, New York, 1999, p.113-148)により行うことができる。
具体的には、例えば、酢酸、トリフルオロ酢酸、塩酸等の酸性条件下に式(III)の化合物を脱保護試薬、例えば、テトラブチルアンモニウムフルオリド[テトラヒドロフラン(以下THFという)1M溶液]と処理することにより、行うことができる。
反応は、溶媒の存在下に行うことが好ましく、そのような溶媒としては、反応に関与しないものであれば如何なるものも使用でき、好ましくは、THF、トルエン等が用いられる。当該脱保護反応は、−20℃から100℃の範囲で円滑に進行する。
The deprotection of the protecting group of the hydroxyl group derived from the compound of formula (III) to the compound of formula (IV) in the production method of the present invention is carried out by a known method (TW Green, “Protective Groups in Organic Synthesis”, A Wiley-Interscience). New York, 1999, p. 113-148).
Specifically, for example, the compound of formula (III) is treated with a deprotection reagent such as tetrabutylammonium fluoride [tetrahydrofuran (hereinafter referred to as THF) 1M solution] under acidic conditions such as acetic acid, trifluoroacetic acid and hydrochloric acid. This can be done.
The reaction is preferably performed in the presence of a solvent. As such a solvent, any solvent can be used as long as it does not participate in the reaction, and preferably THF, toluene and the like are used. The deprotection reaction proceeds smoothly in the range of −20 ° C. to 100 ° C.

以下本発明の製造方法について、後記実施例1の製造法を代表例として、より具体的に説明する。
なお、下記各製造工程で使用する反応溶媒、例えばTHF、ジクロロメタン、酢酸エチル等は、特に断らない限り常法により乾燥したものを用いた。
本発明の製造方法は、以下の3工程からなる製造方法であるが、以下は、式(I)で示されるカテキン類として、次式:
Hereinafter, the production method of the present invention will be described more specifically with the production method of Example 1 described later as a representative example.
The reaction solvents used in the following production steps, such as THF, dichloromethane, ethyl acetate and the like, were those dried by a conventional method unless otherwise specified.
The production method of the present invention is a production method comprising the following three steps. The following are examples of catechins represented by the formula (I):

Figure 0005265144
Figure 0005265144

で示される3’,4’,5,7−テトラヒドロキシ−(+)カテキン、すなわち、(2R,3S)−3’,4’,5,7−テトラヒドロキシフラバン−3−オール(化合物1)を使用して説明する。 3 ', 4', 5,7-tetrahydroxy-(+) catechin represented by (2R, 3S) -3 ', 4', 5,7-tetrahydroxyflavan-3-ol (Compound 1) To explain.

本発明の製造方法における製造工程1は、カテキン類のフェノール性水酸基に、選択的に保護基としてTBDMSが導入された(2R,3S)−3’,4’,5,7−テトラ−O−t−ブチルジメチルシリルフラバン−3−オール(化合物2)を製造する工程である。   In the production process 1 in the production method of the present invention, (2R, 3S) -3 ′, 4 ′, 5,7-tetra-O— in which TBDMS is selectively introduced as a protecting group into the phenolic hydroxyl group of catechins. This is a step for producing t-butyldimethylsilylflavan-3-ol (compound 2).

具体的には、適当な溶媒に、式(1)で示される(+)−カテキン(化合物1)と、イミダゾール、ピリジン、トリエチルアミン等の群から選ばれる少なくとも1種以上の塩基、好ましくはイミダゾールを添加し、氷冷下、t−ブチルジメチルシリルクロライドのTHF溶液を撹拌しながら滴下し、反応溶液中に生じた沈殿をジクロロメタンに溶かし、1〜20時間、室温で撹拌することにより行われる。   Specifically, (+)-catechin (compound 1) represented by the formula (1) and at least one base selected from the group of imidazole, pyridine, triethylamine, etc., preferably imidazole, are added to a suitable solvent. The mixture is added dropwise under ice cooling with a THF solution of t-butyldimethylsilyl chloride with stirring, and the precipitate formed in the reaction solution is dissolved in dichloromethane and stirred at room temperature for 1 to 20 hours.

この製造工程1において用いられる溶媒としては、THF、ジクロロメタン、THF−ジクロロメタン混合溶媒、酢酸エチル等が挙げられる。好ましくは、THF、THF−ジクロロメタン混合溶媒であり、より好ましくは、THF−ジクロロメタン混合溶媒である。
THF−ジクロロメタン混合溶媒100重量部あたりのTHFの含量(重量部)は、好ましくは37〜99.9重量部であり、より好ましくは42〜99.9重量部、さらに好ましくは60〜90重量部、特に好ましくは、70〜80重量部である。
Examples of the solvent used in the production step 1 include THF, dichloromethane, a THF-dichloromethane mixed solvent, and ethyl acetate. Preferred is a mixed solvent of THF and THF-dichloromethane, and more preferred is a mixed solvent of THF-dichloromethane.
The content (parts by weight) of THF per 100 parts by weight of the THF-dichloromethane mixed solvent is preferably 37 to 99.9 parts by weight, more preferably 42 to 99.9 parts by weight, still more preferably 60 to 90 parts by weight. Particularly preferred is 70 to 80 parts by weight.

反応終了後常法に従って、例えば反応溶媒を減圧下除去し、残分にジクロロメタンを加えて抽出し、有機層を水及び飽和食塩水で洗浄し、無水硫酸ナトリウム等で乾燥する。ろ過、濃縮後、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル)で分離精製し、フェノール性水酸基が選択的にシリル基により保護された、3’,4’,5,7−テトラ−t−ブチルジメチルシリル−(+)−カテキン(化合物2)を無色液体として得ることができる。   After completion of the reaction, according to a conventional method, for example, the reaction solvent is removed under reduced pressure, and the residue is extracted by adding dichloromethane, and the organic layer is washed with water and saturated brine, and dried over anhydrous sodium sulfate and the like. After filtration and concentration, the product was separated and purified by silica gel column chromatography (n-hexane: ethyl acetate), and the phenolic hydroxyl group was selectively protected by a silyl group. 3 ′, 4 ′, 5,7-tetra-t- Butyldimethylsilyl-(+)-catechin (compound 2) can be obtained as a colorless liquid.

上記保護基の導入反応(シリル化)に用いる式:A−Xで示されるシリル化剤の使用量は、カテキン類の置換されていないフェノール性水酸基の数に対応して設定することができる。
具体的に設定する使用量は、水酸基の数1に対し、1〜1.1倍量の範囲である。例えば、置換されていないフェノール性水酸基4個を有するカテキンの場合、シリル化剤の使用量は少なくとも4モルである。シリル化は乾燥状態で、例えば乾燥した不活性気体で置換された雰囲気下の反応容器で行う方が好ましい。
The amount of the silylating agent represented by the formula: AX used for the introduction reaction (silylation) of the protecting group can be set according to the number of phenolic hydroxyl groups not substituted in the catechins.
The usage amount specifically set is in the range of 1 to 1.1 times the number of hydroxyl groups. For example, in the case of catechin having 4 unsubstituted phenolic hydroxyl groups, the amount of silylating agent used is at least 4 moles. The silylation is preferably performed in a dry state, for example, in a reaction vessel under an atmosphere substituted with a dry inert gas.

反応温度は、出発原料のカテキンの量、反応時間、反応温度等により異なり特に限定できるものではないが、通常は、氷冷下から常温の範囲で行うことができる。
反応収率は、例えばカテキン1モルに対し、4.4モルのシリル化剤を用いた場合、シリル化物を単離精製した場合でも収率良く得ることができる。実用上は、カテキン1モルに対し、シリル化剤を4モルとし、さらに得られるシリル化物を単離精製しないで、例えば減圧下濃縮し、残分をそのまま次の製造工程に用いることによりさらに収率を向上させることができる。
The reaction temperature varies depending on the amount of the starting material catechin, the reaction time, the reaction temperature and the like, and is not particularly limited, but it can usually be carried out in the range from ice-cooled to room temperature.
For example, when 4.4 mol of silylating agent is used per 1 mol of catechin, the reaction yield can be obtained with good yield even when the silylated product is isolated and purified. Practically, 4 mol of silylating agent is added to 1 mol of catechin, and the resulting silylated product is further concentrated by, for example, concentrating under reduced pressure and using the residue as it is in the next production step without isolation and purification. The rate can be improved.

また、この製造工程に用いられる塩基としては、前記した塩基以外に、通常のシリル化反応に用いることができる有機又は無機の塩基も、特に制限なく使用することもできる。
さらにこの製造工程に用いられる溶媒としては、前記した溶媒以外にも、反応に関与しないものであれば特に制限はなく用いることができる。例えば、クロロホルム、ジクロロメタン、酢酸エチル、好ましくはジクロロメタンが用いられる。
Moreover, as a base used for this manufacturing process, the organic or inorganic base which can be used for a normal silylation reaction besides the above-mentioned base can also be used without a restriction | limiting in particular.
Furthermore, as a solvent used in this production process, there is no particular limitation as long as it does not participate in the reaction other than the above-mentioned solvents. For example, chloroform, dichloromethane, ethyl acetate, preferably dichloromethane is used.

製造工程2は、その一つとして、製造工程1で得られたフェノール性水酸基が保護された式(II)で示されるカテキン類の3−位の水酸基に、アシル基を導入し、式(III)で示される化合物を得る工程である。
具体的には、例えば、3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)を製造する工程で説明する。
In the production process 2, as one of them, an acyl group is introduced into the hydroxyl group at the 3-position of the catechins represented by the formula (II) in which the phenolic hydroxyl group obtained in the production process 1 is protected. Is a step of obtaining a compound represented by
Specifically, for example, a process for producing 3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)-catechin-3-myristate (compound 3) will be described.

本製造工程2は、先ず、前記製造工程1で得られた3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン(化合物2)を、ジクロロメタン等の溶媒に溶かし、氷冷下、トリエチルアミン等の塩基の存在下、ミリストイルクロライド等のアシル活性体、及びN,N−ジメチルアミノピリジンを加え、例えば室温下1〜5時間攪拌することにより実施される。
反応終了後、常法に従って、例えばジクロロメタン等で抽出し、有機層を水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し、ろ過、濃縮し、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル)で分離精製し、目的とする3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)を得ることができる。
In this production process 2, first, the 3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)-catechin (compound 2) obtained in the production process 1 is converted into dichloromethane or the like. It is carried out by dissolving in a solvent, adding an acyl active such as myristoyl chloride and N, N-dimethylaminopyridine in the presence of a base such as triethylamine under ice cooling, and stirring for example at room temperature for 1 to 5 hours.
After completion of the reaction, extraction is performed with, for example, dichloromethane according to a conventional method, and the organic layer is washed with water and saturated brine, dried over anhydrous sodium sulfate, filtered, concentrated, and silica gel column chromatography (n-hexane: ethyl acetate). The desired 3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)-catechin-3-myristate (compound 3) can be obtained.

この製造工程に用いられる塩基としては、前記塩基の他にも、通常のアシル化反応に用いることができる有機又は無機の塩基であれば特に制限はない。
また、この製造工程に用いられる溶媒としては、前記極性溶媒の他にも、反応に関与しないものであれば特に制限されない。例えば、ジエチルエーテル、THF、ジオキサン等のエーテル系溶媒;ジクロロメタン、クロロホルム等のハロゲン化炭化水素系溶媒;ペンタン、ヘキサン、ベンゼン、トルエン、キシレン等の炭化水素系溶媒;DMF、DMSO等が用いられ、好ましくは、THF、ジオキサン、ジクロロメタン又はこれらの混合溶媒である。反応温度は、特に制限はないが、好ましくは氷冷下〜室温である。
The base used in this production process is not particularly limited as long as it is an organic or inorganic base that can be used for a normal acylation reaction in addition to the above-mentioned base.
In addition to the polar solvent, the solvent used in this production process is not particularly limited as long as it does not participate in the reaction. For example, ether solvents such as diethyl ether, THF and dioxane; halogenated hydrocarbon solvents such as dichloromethane and chloroform; hydrocarbon solvents such as pentane, hexane, benzene, toluene and xylene; DMF, DMSO and the like are used. Preferably, THF, dioxane, dichloromethane or a mixed solvent thereof is used. The reaction temperature is not particularly limited, but is preferably under ice cooling to room temperature.

本製造工程2は、また別に、製造工程1で得られたフェノール性水酸基が保護された式(II)で示されるカテキン類の3−位の水酸基にアルキル基を導入した式(III)で示された化合物を得る工程でもある。
当該製造工程は、例えば、製造工程1で得られたフェノール性水酸基が保護された式(II)で示されるカテキン類を、ジメチルホルムアミド等の極性溶媒中に溶解させ、水素化ナトリウム又は水素化カリウム等の塩基の存在下、アルキルハライドと反応させることにより実施される。
反応時間は、反応させる量、溶媒等により異なり特に限定されないが、通常、1〜5時間であり、反応終了後、自体公知の方法により処理され、式(III)で示されるカテキン類の3−位の水酸基にアルキル基を導入した化合物を得ることができる。
This production process 2 is separately represented by the formula (III) in which an alkyl group is introduced into the 3-position hydroxyl group of the catechins represented by the formula (II) in which the phenolic hydroxyl group obtained in the production process 1 is protected. It is also a step of obtaining the prepared compound.
In the production process, for example, the catechins represented by the formula (II) in which the phenolic hydroxyl group protected in the production process 1 is protected are dissolved in a polar solvent such as dimethylformamide, and sodium hydride or potassium hydride is dissolved. By reacting with an alkyl halide in the presence of a base such as
The reaction time varies depending on the amount to be reacted, the solvent, etc., and is not particularly limited, but is usually 1 to 5 hours, and is treated by a method known per se after the completion of the reaction, and the catechins represented by the formula (III) 3- A compound in which an alkyl group is introduced into the hydroxyl group at the position can be obtained.

次いで、製造工程3により、かくして製造された式(III)で示される化合物のフェノール性水酸基の保護基を脱離し、目的とする式(V)で示される3−O−アシル又はアルキル置換−カテキン類誘導体を得る。
具体的には、本製造工程は、例えば、前記製造工程2で得られた3’,4’,5,7−テトラ−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)を、適当な溶媒、例えばTHF等に溶解させ、酢酸を加え、撹拌後、氷冷下、撹拌しながらテトラブチルアンモニウムフルオリド(THF−1M溶液)を加え、室温で1〜4時間撹拌することにより実施される。
Subsequently, the protecting group of the phenolic hydroxyl group of the compound represented by the formula (III) thus produced is removed by the production step 3, and the 3-O-acyl or alkyl-substituted catechin represented by the target formula (V) is removed. A derivative is obtained.
Specifically, this production process is performed by, for example, 3 ′, 4 ′, 5,7-tetra-t-butyldimethylsilyl-(+)-catechin-3-myristate (compound 3) obtained in the production process 2. ) Is dissolved in a suitable solvent such as THF, and acetic acid is added. After stirring, tetrabutylammonium fluoride (THF-1M solution) is added with stirring under ice cooling, and the mixture is stirred at room temperature for 1 to 4 hours. Is implemented.

反応後、常法に従って、例えばジエチルエーテル等で抽出し、有機層を1規定塩酸水溶液、水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥する。ろ過、濃縮後、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル)で分離精製し、濃縮残分をn−ヘキサン、酢酸エチル混液を用いて再結晶することにより、目的とする(+)−カテキン−3−ミリストエート(化合物4)を得ることができる。   After the reaction, it is extracted with, for example, diethyl ether according to a conventional method, and the organic layer is washed with 1N hydrochloric acid aqueous solution, water and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration, the product is separated and purified by silica gel column chromatography (n-hexane: ethyl acetate), and the concentrated residue is recrystallized using a mixed solution of n-hexane and ethyl acetate to obtain the desired (+)-catechin. -3-Myristate (compound 4) can be obtained.

本製造工程で用いられる溶媒としては、前記溶媒の他にも、反応に関与しないものであれば特に制限されず、好ましくは、酢酸、THF等の極性溶媒を使用することもできる。   The solvent used in the present production process is not particularly limited as long as it does not participate in the reaction in addition to the above-mentioned solvent, and a polar solvent such as acetic acid or THF can be preferably used.

なお、式(III)で示されるカテキン類の3−位の水酸基にアルキル基が導入された化合物の脱保護反応も、上記の方法に準じて実施することができる。   In addition, the deprotection reaction of the compound in which an alkyl group is introduced into the 3-position hydroxyl group of the catechins represented by the formula (III) can also be performed according to the above method.

本発明が提供する製造方法においては、出発原料のカテキン類のフェノール性水酸基のみを、選択的に保護することができ、かかる化合物は、反応系から単離することなく、続くアシル化或いはアルキル化をワンポット反応で行い、目的とする3位の水酸基がアシル化若しくはアルキル化された化合物を得ることができる。
したがって、より少ない製造工程数、反応操作により、高収率かつ高純度で簡便に製造することができる利点を有している。
In the production method provided by the present invention, only the phenolic hydroxyl group of the starting catechins can be selectively protected, and such a compound can be subjected to subsequent acylation or alkylation without isolation from the reaction system. Can be carried out in a one-pot reaction to obtain a target compound in which the hydroxyl group at the 3-position is acylated or alkylated.
Therefore, it has the advantage that it can be easily produced with high yield and high purity by a smaller number of production steps and reaction operations.

以下に製造例、試験例を挙げ、本発明をさらに詳しく説明する。ただし、本発明はこれに限定されるものではない。
なお、以下の実施例を図1に化学反応式で示した。
Hereinafter, the present invention will be described in more detail with reference to production examples and test examples. However, the present invention is not limited to this.
The following examples are shown in chemical reaction formulas in FIG.

実施例1:
(製造工程1)3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン;[(2R,3S)−3’,4’,5,7−テトラ−O−t−ブチルジメチルシリルフラバン−3−オール](化合物2)の製造方法:
Example 1:
(Production Process 1) 3 ′, 4 ′, 5,7-Tetra-Ot-butyldimethylsilyl-(+)-catechin; [(2R, 3S) -3 ′, 4 ′, 5,7-tetra- Ot-Butyldimethylsilylflavan-3-ol] (Compound 2):

(+)−カテキン「(2R,3S)−3’,4’,5,7−テトラヒドロキシフラバン−3−オール」(化合物1)(50g、0.172mol)とイミダゾール(104.5g、1.519mol)をTHF200mLに溶かし、氷冷下、t−ブチルジメチルシリルクロライド(114.4g、0.759mol)をTHF100mLに溶かした溶液を撹拌しながら滴下した。生じた沈殿をジクロロメタン100mLに溶かし、18時間室温で撹拌した。反応終了後THFを減圧下蒸発させ、残分にジクロロメタンを加えて抽出し、有機層を水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。ろ過、濃縮後、得られた残渣をシリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル/10:1)で分離精製し、3’,4’,5,7−テトラ−t−ブチルジメチルシリル−(+)−カテキン(化合物2)を無色液体として得た(122.5g、0.164mol、収率94.6%)。   (+)-Catechin “(2R, 3S) -3 ′, 4 ′, 5,7-tetrahydroxyflavan-3-ol” (compound 1) (50 g, 0.172 mol) and imidazole (104.5 g, 1. 519 mol) was dissolved in 200 mL of THF, and a solution of t-butyldimethylsilyl chloride (114.4 g, 0.759 mol) in 100 mL of THF was added dropwise with stirring under ice cooling. The resulting precipitate was dissolved in 100 mL of dichloromethane and stirred at room temperature for 18 hours. After completion of the reaction, THF was evaporated under reduced pressure, dichloromethane was added to the residue for extraction, and the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration, the obtained residue was separated and purified by silica gel column chromatography (n-hexane: ethyl acetate / 10: 1), and 3 ′, 4 ′, 5,7-tetra-t-butyldimethylsilyl- ( +)-Catechin (compound 2) was obtained as a colorless liquid (122.5 g, 0.164 mol, yield 94.6%).

H−NMR(400MHz,CDCl):6.70(1H,s),6.68(1H,s),6.67(1H,s),5.92(1H,d,J=2.2),5.78(1H,d,J=2.2),4.45(1H,d,J=3.9),3.81(1H,m),2.79(1H,dd,J=5.6,16.4),2.40(1H,dd,J=8.7,16.2)0.84−0.56(36H,m),0.10−(−0.19)(24H,m) 1 H-NMR (400 MHz, CDCl 3 ): 6.70 (1H, s), 6.68 (1H, s), 6.67 (1H, s), 5.92 (1H, d, J = 2. 2), 5.78 (1H, d, J = 2.2), 4.45 (1H, d, J = 3.9), 3.81 (1H, m), 2.79 (1H, dd, J = 5.6, 16.4), 2.40 (1H, dd, J = 8.7, 16.2) 0.84-0.56 (36H, m), 0.10-(-0. 19) (24H, m)

(製造工程2)3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート;[(2R,3S)−3’,4’,5,7テトラ−O−t−ブチルジメチルシリルフラバン−3−ミリストエート](化合物3)の製造方法:
前記製造工程1で得た3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン(化合物2)(73.8g,0.099mol)をジクロロメタン200mLに溶かし、氷冷下トリエチルアミン(30.0g,0.296mol)、ミリストイルクロライド(36.6g,0.148mol)、及び、N,N−ジメチルアミノピリジン(50mg)を加え、室温下3時間攪拌した。反応終了後ジクロロメタンで抽出し、有機層を水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。ろ過、濃縮後、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル/3:1)で分離精製し、3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)を黄色液体として得た(93.0g,0.097mol、収率98.3%)。
(Production Process 2) 3 ′, 4 ′, 5,7-Tetra-Ot-butyldimethylsilyl-(+)-catechin-3-myristate; [(2R, 3S) -3 ′, 4 ′, 5 7 Tetra-Ot-butyldimethylsilylflavan-3-myristoate] (Compound 3):
3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)-catechin (compound 2) (73.8 g, 0.099 mol) obtained in the production step 1 was dissolved in 200 mL of dichloromethane. Under ice-cooling, triethylamine (30.0 g, 0.296 mol), myristoyl chloride (36.6 g, 0.148 mol) and N, N-dimethylaminopyridine (50 mg) were added, and the mixture was stirred at room temperature for 3 hours. After completion of the reaction, the mixture was extracted with dichloromethane, and the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration, separation and purification by silica gel column chromatography (n-hexane: ethyl acetate / 3: 1), 3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)- Catechin-3-myristate (Compound 3) was obtained as a yellow liquid (93.0 g, 0.097 mol, yield 98.3%).

H−NMR(400MHz,CDCl):6.61(1H,s),6.58(2H,s),5.94(1H,d,J=1.1),5.76(1H,d,J=1.2),5.07(1H,d,J=1.4),4.80(2H,d,J=2.9),2.54(1H,dd,J=5.1,16.6),2.44(1H,dd,J=5.9,16.8),2.03−1.99(2H,m)1.62−0.93(2H,m)1.62−0.93(23H,m),0.72−0.55(36H,m),0.06−(−0.11)(24H,m) 1 H-NMR (400 MHz, CDCl 3 ): 6.61 (1H, s), 6.58 (2H, s), 5.94 (1H, d, J = 1.1), 5.76 (1H, d, J = 1.2), 5.07 (1H, d, J = 1.4), 4.80 (2H, d, J = 2.9), 2.54 (1H, dd, J = 5) .1, 16.6), 2.44 (1H, dd, J = 5.9, 16.8), 2.03-1.99 (2H, m) 1.62-0.93 (2H, m 1.62-0.93 (23H, m), 0.72-0.55 (36H, m), 0.06-(-0.11) (24H, m)

(製造工程3)(+)−カテキン−3−ミリストエート(化合物4)の製造:
前記製造工程2で得られた3’,4’,5,7−テトラ−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)(93.0g,0.097mol)をTHF100mLに溶かし、酢酸(35.0g,0.583mol)を加え、5分間撹拌した後、氷冷下、撹拌しながらテトラブチルアンモニウムフルオリド(THF−1M溶液)(466mL,0.466mol)を加え、室温で3時間撹拌した。反応終了後ジエチルエーテルで抽出し、有機層を1規定塩酸、水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。ろ過、濃縮後、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル/1:1)で分離精製し、濃縮残分をn−ヘキサン、酢酸エチル混液を用いて再結晶することにより、(+)−カテキン−3−ミリストエート(化合物4)を白色固体として得た(25.8g,0.052mol、収率53.3%)。
(Production Process 3) Production of (+)-catechin-3-myristate (Compound 4):
3 ′, 4 ′, 5,7-tetra-t-butyldimethylsilyl-(+)-catechin-3-myristate (compound 3) (93.0 g, 0.097 mol) obtained in the production step 2 was added to 100 mL of THF. Acetic acid (35.0 g, 0.583 mol) was added and stirred for 5 minutes, and then tetrabutylammonium fluoride (THF-1M solution) (466 mL, 0.466 mol) was added with stirring under ice cooling. Stir at room temperature for 3 hours. After completion of the reaction, the mixture was extracted with diethyl ether, and the organic layer was washed with 1N hydrochloric acid, water and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration, the residue is separated and purified by silica gel column chromatography (n-hexane: ethyl acetate / 1: 1), and the concentrated residue is recrystallized using a mixture of n-hexane and ethyl acetate to obtain (+)- Catechin-3-myristate (compound 4) was obtained as a white solid (25.8 g, 0.052 mol, 53.3% yield).

H−NMR(400MHz,CDCOCD):6.86(1H,d,J=2.2),6.80(1H,d,J=8.3),6.73(1H,d,J=8.3),6.04(1H,d,J=2.2),5.93(1H,d,J=2.2),5.22(1H,m),4.95(2H,d,J=6.1),2.80(1H,dd,J=5.4,16.4),2.60(1H,dd,J=7.0,16.3),2.22−2.16(2H,m)1.46−1.42(2H,m)1.32−1.25(20H,m),0.93−0.84(3H,m) 1 H-NMR (400 MHz, CD 3 COCD 3 ): 6.86 (1H, d, J = 2.2), 6.80 (1H, d, J = 8.3), 6.73 (1H, d , J = 8.3), 6.04 (1H, d, J = 2.2), 5.93 (1H, d, J = 2.2), 5.22 (1H, m), 4.95. (2H, d, J = 6.1), 2.80 (1H, dd, J = 5.4, 16.4), 2.60 (1H, dd, J = 7.0, 16.3), 2.22-2.16 (2H, m) 1.46-1.42 (2H, m) 1.32-1.25 (20H, m), 0.93-0.84 (3H, m)

実施例2:
前記実施例1の各製造工程に準拠して、下記化合物を合成した。
置換基Rが、−C(O)(CH)=(CH)CH (cis体)で表される化合物。
(1)製造工程2の収率(100.0%)、
(2)製造工程3の収率(36.4%)(酢酸添加し、反応させた)。
製造工程3で得られた化合物はH−NMRにて同定した。
Example 2:
The following compounds were synthesized according to the production steps of Example 1.
A compound in which the substituent R is represented by —C (O) (CH 2 ) 8 = (CH 2 ) 8 CH 3 (cis isomer).
(1) Yield of production process 2 (100.0%),
(2) Yield of production process 3 (36.4%) (Acetic acid was added and reacted).
The compound obtained in production step 3 was identified by 1 H-NMR.

H−NMR(400MHz,CDOD):6.69(1H,d,J=2.0),6.65(1H,d,J=4.0),6.58(1H,d,J=2.0),5.84(1H,d,J=2.4),5.79(1H,d,J=2.0),5.26−5.23(2H,m),5.21(1H,m),4.74(1H,m),2.71(1H,dd,J=5.2,16.4),2.50(1H,dd,J=7.2,16.4),2.11(2H,t,J=3.6)1.95−1.92(4H,m),1.38−1.31(2H,m),1.19−1.04(20H,m),0.89−0.78(3H,m) 1 H-NMR (400 MHz, CD 3 OD): 6.69 (1H, d, J = 2.0), 6.65 (1H, d, J = 4.0), 6.58 (1H, d, J = 2.0), 5.84 (1H, d, J = 2.4), 5.79 (1H, d, J = 2.0), 5.26-5.23 (2H, m), 5.21 (1H, m), 4.74 (1H, m), 2.71 (1H, dd, J = 5.2,16.4), 2.50 (1H, dd, J = 7.2) 16.4), 2.11 (2H, t, J = 3.6) 1.95-1.92 (4H, m), 1.38-1.31 (2H, m), 1.19- 1.04 (20H, m), 0.89-0.78 (3H, m)

実施例3:
前記実施例1の各製造工程に準拠して、下記化合物を合成した。
置換基Rが、−C(O)(CH)CH で表される化合物。
(1)製造工程2の収率(86.9%)、
(2)製造工程3の収率(16.6%)(酢酸無添加の条件下で反応させた)。
製造工程3で得られた化合物はH−NMRにて同定した。
Example 3:
The following compounds were synthesized according to the production steps of Example 1.
A compound in which the substituent R is represented by —C (O) (CH 2 ) 9 CH 3 .
(1) Yield of production process 2 (86.9%),
(2) Yield of production process 3 (16.6%) (reacted under the condition without addition of acetic acid).
The compound obtained in production step 3 was identified by 1 H-NMR.

H−NMR(400MHz,CDOD):7.15(1H,d,J=2.0),7.11(1H,d,J=2.7),7.03(1H,d,J=2.0),6.31(1H,d,J=2.4),6.25(1H,d,J=2.4),5.58−5.53(1H,m),5.20(1H,m),3.16(1H,dd,J=5.4,16.3),2.96(1H,dd,J=6.9,16.3),2.58−2.50(2H,m)1.81−1.74(2H,m),1.67−1.48(14H,m),1.27−1.20(3H,m) 1 H-NMR (400 MHz, CD 3 OD): 7.15 (1H, d, J = 2.0), 7.11 (1H, d, J = 2.7), 7.03 (1H, d, J = 2.0), 6.31 (1H, d, J = 2.4), 6.25 (1H, d, J = 2.4), 5.58-5.53 (1H, m), 5.20 (1H, m), 3.16 (1H, dd, J = 5.4, 16.3), 2.96 (1H, dd, J = 6.9, 16.3), 2.58 -2.50 (2H, m) 1.81-1.74 (2H, m), 1.67-1.48 (14H, m), 1.27-1.20 (3H, m)

実施例2〜3の結果から、脱保護の工程では、脱保護を溶媒中、酢酸の存在下、テトラブチルアンモニウムフルオリド(THF−1M溶液)を用いて行うことにより、さらに効率よく目的とする3−O−アシル置換−カテキン類が得られることが判明する。   From the results of Examples 2 to 3, in the deprotection step, deprotection is performed more efficiently in the solvent using tetrabutylammonium fluoride (THF-1M solution) in the presence of acetic acid. It turns out that 3-O-acyl-substituted-catechins are obtained.

実施例4:3−O−アルキル置換−カテキン誘導体の製造方法
(製造工程1)
前記実施例1の製造工程1で得られた化合物を出発原料として用いた。
Example 4: Method for producing 3-O-alkyl-substituted-catechin derivatives (production process 1)
The compound obtained in the production step 1 of Example 1 was used as a starting material.

(製造工程2)3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−テトラデカンエーテル;[(2R,3S)−3’,4’,5,7テトラ−O−t−ブチルジメチルシリルフラバン−3−テトラデカンエーテル]の製造方法:
前記製造工程1で得られた3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン(3.0g,0.004mol)をDMF50mLに溶かし、氷冷下60%NaH(0.250g,0.006mol)、テトラデカンクロライド(1.191g,0.006mol)を加え、室温下3時間攪拌した。反応終了後ジクロロメタンを加え、有機層を水及び飽和食塩水で洗浄した。有機層から得られた生成物、及び析出した固体の精製は行わず、黒色固体を得た(収量8.12g)
(Production Process 2) 3 ′, 4 ′, 5,7-Tetra-Ot-butyldimethylsilyl-(+)-catechin-3-tetradecane ether; [(2R, 3S) -3 ′, 4 ′, 5 , 7 Tetra-Ot-butyldimethylsilylflavan-3-tetradecane ether]:
3 ′, 4 ′, 5,7-Tetra-Ot-butyldimethylsilyl-(+)-catechin (3.0 g, 0.004 mol) obtained in the production step 1 was dissolved in 50 mL of DMF, and cooled with ice. 60% NaH (0.250 g, 0.006 mol) and tetradecan chloride (1.191 g, 0.006 mol) were added, and the mixture was stirred at room temperature for 3 hours. After completion of the reaction, dichloromethane was added, and the organic layer was washed with water and saturated brine. The product obtained from the organic layer and the precipitated solid were not purified, and a black solid was obtained (yield 8.12 g).

(製造工程3)
前記製造工程2で得られた黒色固体をTHF100mL、酢酸(3.10g,0.052mol)を加え、5分間撹拌した後、氷冷下、撹拌しながらテトラブチルアンモニウムフルオリド(THF−1M溶液)(41.3mL,0.413mol)を加え、室温で3時間撹拌した。反応終了後ジエチルエーテルで抽出し、有機層を1規定塩酸、水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。ろ過、濃縮後、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル/1:1)で分離精製し、濃縮残分をn−ヘキサン、酢酸エチル混液を用いて再結晶することにより、(+)−カテキン−3−テトラデカンエーテルを黒色固体として得た(0.447g,0.002mol、製造工程2〜3の収率50.0%)。
(Manufacturing process 3)
To the black solid obtained in the production step 2, 100 mL of THF and acetic acid (3.10 g, 0.052 mol) were added and stirred for 5 minutes, and then tetrabutylammonium fluoride (THF-1M solution) with stirring under ice cooling. (41.3 mL, 0.413 mol) was added and stirred at room temperature for 3 hours. After completion of the reaction, the mixture was extracted with diethyl ether, and the organic layer was washed with 1N hydrochloric acid, water and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration, the residue is separated and purified by silica gel column chromatography (n-hexane: ethyl acetate / 1: 1), and the concentrated residue is recrystallized using a mixture of n-hexane and ethyl acetate to obtain (+)- Catechin-3-tetradecane ether was obtained as a black solid (0.447 g, 0.002 mol, yield 50.0% of production steps 2 to 3).

H−NMR(400MHz,CDCOCD):6.79(1H,d,J=2.0),6.68(1H,d,J=2.0),6.66(1H,d,J=1.6),5.89(1H,d,J=2.4),5.80(1H,d,J=2.4),4.51(1H,d,J=7.2),3.92(1H,m),2.93(2H,t,J=8.4),2.63(1H,dd,J=7.6,16.2),2.27(1H,dd,J=8.2,16.2),1.37−1.33(2H,m),1.21−0.74(25H,m) 1 H-NMR (400 MHz, CD 3 COCD 3 ): 6.79 (1H, d, J = 2.0), 6.68 (1H, d, J = 2.0), 6.66 (1H, d , J = 1.6), 5.89 (1H, d, J = 2.4), 5.80 (1H, d, J = 2.4), 4.51 (1H, d, J = 7. 2), 3.92 (1H, m), 2.93 (2H, t, J = 8.4), 2.63 (1H, dd, J = 7.6, 16.2), 2.27 ( 1H, dd, J = 8.2, 16.2), 1.37-1.33 (2H, m), 1.21-0.74 (25H, m)

実施例5〜7:
前記実施例1の製造工程1において反応溶媒の種類と組合せを変化させた以外は実施例1の製造工程に準拠して3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン(化合物2)を調製した。
その結果は表1に示すとおりであった。
Examples 5-7:
3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl in accordance with the production process of Example 1 except that the type and combination of reaction solvents were changed in Production Process 1 of Example 1. -(+)-Catechin (compound 2) was prepared.
The results are shown in Table 1.

Figure 0005265144
Figure 0005265144

実施例8:ワンポット合成(製造工程1及び2をワンポットによる実施)
3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)の製造方法:
(+)−カテキン:[(2R,3S)−3’,4’,5,7−テトラヒドロキシフラバン−3−オール](化合物1)(50g、0.172mol)とイミダゾール(104.5g、1.519mol)をTHF200mLに溶かし、氷冷下、t−ブチルジメチルシリルクロライド(114.4g、0.759mol)をTHF100mLに溶かした溶液を撹拌しながら滴下した。生じた沈殿をジクロロメタン100mLに溶かし、18時間室温で撹拌した(このときの3’,4’,5,7−テトラ−t−ブチルジメチルシリル−(+)−カテキンの収率94.6%)。次いで、氷冷下トリエチルアミン(17.4g,0.172mol)、ミリストイルクロライド(42.5g,0.172mol)、及び、N,N−ジメチルアミノピリジン(50mg)を加え、室温下3時間攪拌した。反応終了後ジクロロメタンで抽出し、有機層を水及び飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した。ろ過、濃縮後、シリカゲルカラムクロマトグラフィー(n−ヘキサン:酢酸エチル/3:1)で分離精製し、3’,4’,5,7−テトラ−O−t−ブチルジメチルシリル−(+)−カテキン−3−ミリストエート(化合物3)を黄色液体として得た(収率93%)。
Example 8: One-pot synthesis (Production steps 1 and 2 are carried out in one pot)
Method for producing 3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)-catechin-3-myristate (compound 3):
(+)-Catechin: [(2R, 3S) -3 ′, 4 ′, 5,7-tetrahydroxyflavan-3-ol] (Compound 1) (50 g, 0.172 mol) and imidazole (104.5 g, 1 .519 mol) was dissolved in 200 mL of THF, and a solution of t-butyldimethylsilyl chloride (114.4 g, 0.759 mol) in 100 mL of THF was added dropwise with stirring under ice cooling. The resulting precipitate was dissolved in 100 mL of dichloromethane and stirred at room temperature for 18 hours (the yield of 3 ′, 4 ′, 5,7-tetra-t-butyldimethylsilyl-(+)-catechin at this time was 94.6%). . Subsequently, triethylamine (17.4 g, 0.172 mol), myristoyl chloride (42.5 g, 0.172 mol) and N, N-dimethylaminopyridine (50 mg) were added under ice cooling, and the mixture was stirred at room temperature for 3 hours. After completion of the reaction, the mixture was extracted with dichloromethane, and the organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. After filtration and concentration, separation and purification by silica gel column chromatography (n-hexane: ethyl acetate / 3: 1), 3 ′, 4 ′, 5,7-tetra-Ot-butyldimethylsilyl-(+)- Catechin-3-myristoate (compound 3) was obtained as a yellow liquid (yield 93%).

上記の各実施例の結果から、製造工程1において用いられる溶媒としては、THF、ジクロロメタン、THF−ジクロロメタン混合溶媒、酢酸エチル等が挙げられる。
好ましくは、THF、THF−ジクロロメタン混合溶媒であり、より好ましくは、THF−ジクロロメタン混合溶媒である。
THF−ジクロロメタン混合溶媒の場合には、混合溶媒100重量部あたりのTHFの含量(重量部)は、好ましくは37〜99.9重量部であり、より好ましくは42〜99.9重量部、さらに好ましくは60〜90重量部、特に好ましくは、70〜80重量部である。
そのTHF−ジクロロメタンの混合相関を図2に示した。
From the results of the above examples, examples of the solvent used in the production step 1 include THF, dichloromethane, a THF-dichloromethane mixed solvent, and ethyl acetate.
Preferred is a mixed solvent of THF and THF-dichloromethane, and more preferred is a mixed solvent of THF-dichloromethane.
In the case of a THF-dichloromethane mixed solvent, the content (parts by weight) of THF per 100 parts by weight of the mixed solvent is preferably 37 to 99.9 parts by weight, more preferably 42 to 99.9 parts by weight, Preferably it is 60-90 weight part, Most preferably, it is 70-80 weight part.
The mixed correlation of THF-dichloromethane is shown in FIG.

本発明の製造方法により、カテキン類のフラバン骨格における3位の水酸基に、様々なアシル基、アルキル基を選択的に導入した3−O−置換−カテキン類誘導体を、簡便な製造方法で高純度、かつ収率で提供することができる。
本発明の製造方法は、脱保護基の製造工程で従来のような還元設備等特別の装置を用いることなく、目的物を得ることができるので、産業上極めて有用である。
According to the production method of the present invention, 3-O-substituted-catechin derivatives having various acyl groups and alkyl groups selectively introduced into the hydroxyl group at the 3-position in the flavan skeleton of catechins can be highly purified by a simple production method. And in a yield.
The production method of the present invention is extremely useful industrially because the desired product can be obtained in the production process of the deprotecting group without using a special apparatus such as a conventional reduction facility.

本発明の実施例1を具体的反応式で示した図である。It is the figure which showed Example 1 of this invention with the concrete reaction type | formula. 本発明の製造工程1におけるシリル保護基の導入に用いる溶媒と、目的物の収率との関係を示す図である。 図中、横軸はTHF−ジクロロメタン混合溶媒100重量部に対するTHFの含量を示し、縦軸は目的物の収率(%)を示す。It is a figure which shows the relationship between the solvent used for introduction | transduction of the silyl protecting group in the manufacturing process 1 of this invention, and the yield of a target object. In the figure, the horizontal axis indicates the content of THF relative to 100 parts by weight of the THF-dichloromethane mixed solvent, and the vertical axis indicates the yield (%) of the target product.

Claims (7)

下記式(I):
Figure 0005265144
(式中、Raは水素原子又は水酸基を表す)
で表されるカテキン類に、塩基の存在下、次式:
A−X
(式中、Aは水酸基のシリル保護基を表し、Xは活性残基を表す)
で示される化合物と反応させ、式(I)のフェノール性水酸基に選択的に保護基を導入した次式(II):
Figure 0005265144
(式中、Rcは水素原子又は基:OAを表し、Aは前記定義と同一である)
で表される化合物とし、次いで下記式(V):
R−Y (V)
[式中、Rは炭素数1〜22の置換されていてもよいアルキル基、又はRbC(=O)−基で表されるアシル基(Rbは炭素数1〜22の置換されていてもよいアルキル基を表す)を表し、Yは活性残基を表す]
で表される化合物と反応させ、下記式(III):
Figure 0005265144
(式中、A、Rc及びRは前記定義と同一である)
で表される化合物とした後、脱保護をすることを特徴とする下記式(IV):
Figure 0005265144
(式中、Ra及びRは前記定義と同一である)
で表される3−O−アシル又はアルキル置換−カテキン類誘導体の製造方法。
The following formula (I):
Figure 0005265144
(In the formula, Ra represents a hydrogen atom or a hydroxyl group)
In the presence of a base, the following formula:
AX
(In the formula, A represents a silyl protecting group of a hydroxyl group, and X represents an active residue)
Wherein the protecting group is selectively introduced into the phenolic hydroxyl group of formula (I):
Figure 0005265144
(Wherein Rc represents a hydrogen atom or a group: OA, and A is the same as defined above)
And then the following formula (V):
RY (V)
[Wherein, R represents an alkyl group having 1 to 22 carbon atoms which may be substituted, or an acyl group represented by an RbC (═O) — group (Rb may be substituted having 1 to 22 carbon atoms. Represents an alkyl group, and Y represents an active residue]
And a compound represented by the following formula (III):
Figure 0005265144
(Wherein A, Rc and R are the same as defined above)
And then deprotecting the compound represented by the following formula (IV):
Figure 0005265144
(Wherein Ra and R are as defined above)
A method for producing a 3-O-acyl or alkyl-substituted catechin derivative represented by the formula:
下記式(II):
Figure 0005265144
(式中、A及びRcは、前記請求項1の定義と同一である)
で表される化合物と、下記式(V):
R−Y (V)
(式中、R及びYは前記請求項1の定義と同一である)
で表される化合物と反応させ、下記式(III):
Figure 0005265144
(式中、A、Rc及びRは前記請求項1の定義と同一である)
で表される化合物とした後、次いで脱保護をすることを特徴とする下記式(IV):
Figure 0005265144
(式中、Ra及びRは前記請求項1の定義と同一である)
で表される3−O−アシル又はアルキル置換−カテキン類誘導体の製造方法。
Formula (II) below:
Figure 0005265144
Wherein A and Rc are the same as defined in claim 1 above.
And a compound represented by the following formula (V):
RY (V)
Wherein R and Y are the same as defined in claim 1 above.
And a compound represented by the following formula (III):
Figure 0005265144
Wherein A, Rc and R are as defined in claim 1 above.
And then deprotecting the compound represented by the following formula (IV):
Figure 0005265144
Wherein Ra and R are as defined in claim 1 above.
A method for producing a 3-O-acyl or alkyl-substituted catechin derivative represented by the formula:
下記式(I):
Figure 0005265144
(式中、Raは水素原子又は水酸基を表す)
で表されるカテキン類に、塩基の存在下、次式:
A−X
(式中、A及びXは前記請求項1の定義と同一である)
で示される化合物と反応させ、式(I)のフェノール性水酸基に選択的に保護基を導入した次式(II):
Figure 0005265144
(式中、A及びRcは前記請求項1の定義と同一である)
で表される化合物とし、次いで下記式:
R−Y
(式中、R及びYは前記請求項1の定義と同一である)
で表される化合物と反応させることを特徴とする、下記式(III):
Figure 0005265144
(式中、A、Rc及びRは前記請求項1の定義と同一である)
で表される化合物の製造方法。
The following formula (I):
Figure 0005265144
(In the formula, Ra represents a hydrogen atom or a hydroxyl group)
In the presence of a base, the following formula:
AX
Wherein A and X are the same as defined in claim 1 above.
Wherein the protecting group is selectively introduced into the phenolic hydroxyl group of formula (I):
Figure 0005265144
Wherein A and Rc are the same as defined in claim 1 above.
And then the following formula:
RY
Wherein R and Y are the same as defined in claim 1 above.
It is made to react with the compound represented by following formula (III):
Figure 0005265144
Wherein A, Rc and R are as defined in claim 1 above.
The manufacturing method of the compound represented by these.
下記式(I):
Figure 0005265144
(式中、Raは水素原子又は水酸基を表す)
で表されるカテキン類に、塩基の存在下、次式:
A−X
(式中、A及びXは前記請求項1の定義と同一である)
で示される化合物と反応させ、式(I)のフェノール性水酸基に選択的に保護基を導入した次式(II):
Figure 0005265144
(式中、A及びRcは、前記請求項1の定義と同一である)
で表される化合物の製造方法。
The following formula (I):
Figure 0005265144
(In the formula, Ra represents a hydrogen atom or a hydroxyl group)
In the presence of a base, the following formula:
AX
Wherein A and X are the same as defined in claim 1 above.
Wherein the protecting group is selectively introduced into the phenolic hydroxyl group of formula (I):
Figure 0005265144
Wherein A and Rc are the same as defined in claim 1 above.
The manufacturing method of the compound represented by these.
シリル保護基が、t−ブチルジメチルシリル基である請求項1記載の製造方法。 The process according to claim 1 , wherein the silyl protecting group is a t-butyldimethylsilyl group. 式(III)の化合物から式(IV)の化合物への脱保護を、溶媒中、酢酸の存在下、テトラブチルアンモニウムフルオリドを用いて行うことを特徴とする請求項1又は2記載の製造方法。   The method according to claim 1 or 2, wherein the deprotection of the compound of formula (III) to the compound of formula (IV) is carried out using tetrabutylammonium fluoride in a solvent in the presence of acetic acid. . 式(II)の化合物を単離することなく式(III)への誘導をワンポットで反応させる請求項1又は3に記載の製造方法。   The production method according to claim 1 or 3, wherein the induction to the formula (III) is reacted in one pot without isolating the compound of the formula (II).
JP2007168786A 2007-06-27 2007-06-27 Novel process for producing 3-O-substituted-catechin derivatives Expired - Fee Related JP5265144B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007168786A JP5265144B2 (en) 2007-06-27 2007-06-27 Novel process for producing 3-O-substituted-catechin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007168786A JP5265144B2 (en) 2007-06-27 2007-06-27 Novel process for producing 3-O-substituted-catechin derivatives

Publications (2)

Publication Number Publication Date
JP2009007272A JP2009007272A (en) 2009-01-15
JP5265144B2 true JP5265144B2 (en) 2013-08-14

Family

ID=40322726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007168786A Expired - Fee Related JP5265144B2 (en) 2007-06-27 2007-06-27 Novel process for producing 3-O-substituted-catechin derivatives

Country Status (1)

Country Link
JP (1) JP5265144B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233810B (en) * 2020-01-18 2023-03-21 安徽农业大学 Preparation method and application of hydroxycinnamoyl ester type catechin
JP7379415B2 (en) * 2021-06-01 2023-11-14 花王株式会社 Method for producing catechin conjugate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157262A1 (en) * 1996-04-30 2004-08-12 Michel Kohl Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
WO2004005229A1 (en) * 2002-07-08 2004-01-15 Pfizer Products Inc. Modulators of the glucocorticoid receptor
JP2006249056A (en) * 2005-03-07 2006-09-21 Mitsui Norin Co Ltd Uterine cancer inhibitor

Also Published As

Publication number Publication date
JP2009007272A (en) 2009-01-15

Similar Documents

Publication Publication Date Title
JP5202635B2 (en) Processes and intermediates for the preparation of integrase inhibitors
JP6689935B2 (en) New synthetic method of catechin
TWI697489B (en) A novel synthesis process of polyphenols
JP5265144B2 (en) Novel process for producing 3-O-substituted-catechin derivatives
JP2001247594A (en) Method of producing flavonoid compound
US6175023B1 (en) Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin III
CN1218475A (en) Taxane derivatives preparation thereof and formulation containing them
JPWO2018220888A1 (en) PGE1 core block derivative and method for producing the same
CN108314689B (en) Synthesis method of 4, 11-diacyl bergenin derivative
JP3194581B2 (en) Gibberellin separation method
CZ20697A3 (en) Process of stereoselective preparation of heterobicyclic alcohol enantiomer
JPH07112968A (en) Production of 1alpha,24-dihydroxycholecalciferol
CN1310920C (en) Prepn of racemized and optically active poon essence A and its analog
JP3829273B2 (en) Process for producing optically active flavanones and chromanones
RU2315747C2 (en) Method for production of acetylene compound
JPH029585B2 (en)
JP5291335B2 (en) Tricine production method
JP2007084536A (en) Method for producing procyanidin b1-b4 and catechin polymer
RO129083B1 (en) Polyfunctional cyclopentanic chloroester and ()-lactone oxabicyclo [3.3.0] octane key compounds prepared by stereoselective transformation of ()-lactone intermediates and processes for preparing the same
EP1997815B1 (en) Method for producing flavan derivatives
CN104829644B (en) A kind of preparation method of (S) tertiary butyl dimethyl Si base glutaric acid list benzyl ester monoamides
KR20240004472A (en) Method for synthesizing xanthohumol
JP2010006729A (en) Method for producing theaflavins
JP3495774B2 (en) Method for producing 1-hydroxyindoles
JPH07206751A (en) Production of ticyclic compound

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100618

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20101013

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101102

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120925

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120926

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130405

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130409

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130425

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130501

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5265144

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees